Skip to main content

Hemofiltration clearance of flecainide in a patient with acute renal failure

Abstract

Flecainide, a new antiarrhythmic drug, has been shown not no be removed to a significant extent by hemodialysis or peritoneal dialysis, in spite of a high renal clerance. Its systemic and hemofiltrate clearances, measured in a patient under continuous hemofiltration, were 402 and 19.7 ml/min respectively. The clearance ratio of less than 5% makes the contribution of hemofiltration to the elimination of flecainide clinically negligeable.

This is a preview of subscription content, access via your institution.

References

  1. Borgeat A, Goy JJ, Maendly R, Kaufman U, Grbic M, Sigwart U (1986) Flecainide versus quinidine for conversion of atrial fibrillation to sinus rhythm. Am J Cardiol 58:496

    Google Scholar 

  2. Cafruny EJ (1977) Renal tubular handling of drugs. M J Med 62:490

    Google Scholar 

  3. Gomeni R (1984) PHARM: an interactive graphic program for individual and population pharmacokinetic parameter estimation. Comput Biol Med 14:25

    Google Scholar 

  4. Holmes B, Heel RC (1985) Flecainide. A preliminary review of its pharmacodynamic properties and therapeutic efficacy. Drugs 29:1

    Google Scholar 

  5. Roden DM, Woosley RL (1986) Flecainide. N Engl J Med 315:36

    Google Scholar 

Download references

Author information

Affiliations

Authors

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Borgeat, A., Biollaz, J., Freymond, B. et al. Hemofiltration clearance of flecainide in a patient with acute renal failure. Intensive Care Med 14, 236–237 (1988). https://doi.org/10.1007/BF00717997

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00717997

Key words

  • Hemofiltration
  • Flecainide
  • Atrial fibrillation
  • Pharmacokinetics
  • Renal failure